📰 Kevin Wake News
Kevin Wake News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Kevin Wake. Real-time updates on events, politics, business and more.
December 12, 2023
The Star spoke to Kansas City area experts for information regarding the newest treatments for sickle cell disease.
December 9, 2023
The breakthrough sickle cell treatment is the first approved therapy based on CRISPR, the gene editing tool that won its inventors the Nobel Prize in 2020.
December 8, 2023
The breakthrough sickle cell treatment is the first approved therapy based on CRISPR, the gene editing tool that won its inventors the Nobel Prize in 2020.
December 8, 2023
The breakthrough sickle cell treatment is the first approved therapy based on CRISPR, the gene editing tool that won its inventors the Nobel Prize in 2020.
December 8, 2023
The breakthrough sickle cell treatment is the first approved therapy based on CRISPR, the gene editing tool that won its inventors the Nobel Prize in 2020.
December 8, 2023
The breakthrough sickle cell treatment is the first approved therapy based on CRISPR, the gene editing tool that won its inventors the Nobel Prize in 2020.
December 8, 2023
The breakthrough sickle cell treatment is the first approved therapy based on CRISPR, the gene editing tool that won its inventors the Nobel Prize in 2020.
October 30, 2023
Sickle cell disease plagues tens of thousands of Americans every year, and the vast majority of those suffering are Black Americans. Sickle cell disease is a blood disorder where the red blood cells become misshapen, this can cause extreme pain, fatigue, blood clotting, and even death. The only cure for the painful disorder has been a bone marrow transplant, which can be extremely difficult to obtain.
April 11, 2023
Kevin Wake is sharing his experience being denied proper treatment in an emergency room in order to draw attention to health disparities faced by sickle cell patients.
February 7, 2023
Unintentional and implicit biases are the ones we dont realize we have, especially when weve worked hard to have a limited amount of biases as possible.